News
Strong Q1 sales of $137.3M showcase Madrigal Pharmaceuticals, Inc.'s Rezdiffra's growth in non-cirrhotic NASH. Click for my ...
Lisandro Madrigal, the owner of Sacramento’s taqueria chain Chando’s Tacos, is scheduled to appear in court at 8:45 a.m. on ...
Madrigal will study SYH2086 in combination with Rezdiffra for metabolic dysfunction-associated steatohepatitis, aiming for ...
CEO touts 'amazing' sales success of new drug, but firm's stock slumps Montco firm's shares soar on huge sales increase of ...
Madrigal Pharmaceuticals ( NASDAQ: MDGL) said it has signed a global licensing deal with CSPC Pharmaceutical for SYH2086, a ...
3d
US Weekly on MSNScheana Shay, Peter Madrigal Argue Over Loyalty to Lisa Vanderpump: ‘Crazy How Quick Things Changed’Scheana Shay's candid comments about her falling out with Lisa Vanderpump upset one of her former Vanderpump Rules costars.
U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for a ...
Madrigal Pharmaceuticals secures global rights to SYH2086, aiming to enhance MASH treatment with innovative combination ...
An experimental Latin music series, Bajo La Luna will bring Y La Bamba, Silvia Pérez Cruz and La Muchacha to the Ford Theatre ...
Madrigal Pharmaceuticals Inc.’s long-awaited business development pact became reality by way of an exclusive global license ...
USA-based Madrigal Pharmaceuticals today announced that it has entered into an exclusive global license agreement with CSPC ...
The idea is that SYH2086 can be paired with Rezdiffra, a selective thyroid hormone receptor agonist that became the first FDA-approved drug for metabolic dysfunction-associated steatohepatitis (MASH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results